Morningstar - Tox Free Solutions Ltd (TOXFF) Corporate Action - Tox Captures Growth in Medical Waste Acquiring Daniels Health; FVE up to AUD 2.90

Report

Morningstar

Tim Mann

EUR 101.80 For Business Accounts Only

Corporate Action - Tox Captures Growth in Medical Waste Acquiring Daniels Health; FVE up to AUD 2.90

Tox Free Solutions announced it had acquired Daniels Health for AUD 186 million. Daniels delivers a market leading position in domestic medical waste solutions, collections and treatment, and operates 17 sites across Australia, including two incineration facilities in Sydney and Melbourne, as well as three joint venture managed sites in New Zealand. Customers include private and public hospitals, medical centres and aged care facilities with potential revenue synergies coming from cross sell of ...

26/10/2016 12 EN

Underlying

Tox Free Solutions Ltd

Tox Free Solutions is engaged in the provision of industrial cleaning and waste management. Co. has three main business segments: Waste Services, Industrial Services, and Technical and Environmental Services. The Waste Services segment includes the collection, resource recovery, recycling and disposal of solid, industrial, municipal and commercial wastes. The Industrial Services segment provides onsite industrial cleaning to the oil and gas, mining, heavy manufacturing, civil infrastructure, municipal and utilities sectors. The Technical and Environmental Services segment comprises a national network of liquid and hazardous waste management facilities throughout Australia.

See profile

AU000000TOX6 Australia

Provider

Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

See profile

Analysts

Tim Mann

Other Reports on these Companies

Independent Investment Research

Monthly LMI Update Independent Investment Research

Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked. This compares to the total dividends of 5 cents per share in FY20. The Board has confirmed that, in...

August 6, 2021 August 6, 2021 10 EN

Fundamental Research

Feasibility Study Results in December to be a Catalyst for this Junior

EUR 18.27

November 25, 2019 November 25, 2019 14 EN

Morningstar

Toxfree Nears Sale Completion as Shareholders Approve Transaction With Cleanaway

No-moat Toxfree has announced that it has received approval from more than 99% of shareholders to proceed with the scheme of arrangement under which Cleanaway Waste Management will acquire the business. The Federal Court will weigh in on May 10, 2018, and assuming approval, Toxfreeâ€™s shares will be suspended from trading on May 11. We maintain our $3.425 per share fair value estimate, matching the all-cash acquisition offer from Cleanaway. Upon completion of the scheme, shareholders will receive...

EUR 100.00

May 3, 2018 May 3, 2018 12 EN

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Contract manufacturer Lonza reported solid half-year results, with over CHF 2.9 billion in total sales year to date, up about 6.4% from last year and boosted by foreign exchange tailwinds. Core EBITDA margin expanded 30 basis points from last year to about 27.8%, helped slightly by new accounting standards. Management indicated that it continues to expect mid- to high-single-digit sales growth in 2019. We are maintaining our fair value estimate of CHF 210 per share and our no-moat rating. The ph...

EUR 100.00

July 25, 2019 July 25, 2019 13 EN

Joe Gemino

Joe Gemino

Sasol Provides Full-Year Production Update

No-moat Sasol provided an update on its full-year fiscal 2019 production metrics that included relatively stable liquids production. For the full year ended June 30, Sasol produced 1,470 thousand barrels of crude oil and condensate a day compared with 1,469 mboe/d in the year-ago period. However, declines continued with the companyâ€™s natural gas production, down 4% to 130.3 billion cubic feet compared with the period ended June 30, 2018. Sasol also reported flat refined products of 31.4 mmboe/d ...

EUR 100.00

July 25, 2019 July 25, 2019 12 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

We don't expect any major changes to our AstraZeneca fair value estimate following second-quarter results that largely fell in line with our expectations and slightly ahead of consensus expectations. Overall, the company is posting leading Big Pharma sales growth with total sales up 18% operationally year over year, led by impressive cancer drug sales growth of 57%. Astra's ability to continue to bring next generation drugs to the market that address unmet medical need (especially in oncology) s...

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Corporate Action - Tox Captures Growth in Medical Waste Acquiring Daniels Health; FVE up to AUD 2.90

Monthly LMI Update Independent Investment Research

Feasibility Study Results in December to be a Catalyst for this Junior

Toxfree Nears Sale Completion as Shareholders Approve Transaction With Cleanaway

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Sasol Provides Full-Year Production Update

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe